DK1158963T3 - Sammensætninger af betahistin med kontrolleret frigivelse - Google Patents

Sammensætninger af betahistin med kontrolleret frigivelse

Info

Publication number
DK1158963T3
DK1158963T3 DK00910723T DK00910723T DK1158963T3 DK 1158963 T3 DK1158963 T3 DK 1158963T3 DK 00910723 T DK00910723 T DK 00910723T DK 00910723 T DK00910723 T DK 00910723T DK 1158963 T3 DK1158963 T3 DK 1158963T3
Authority
DK
Denmark
Prior art keywords
compositions
controlled release
betahistine
release betahistine
controlled
Prior art date
Application number
DK00910723T
Other languages
English (en)
Inventor
Flavio Fabiani
Enrico Frimonti
Mauro Valenti
Original Assignee
Formenti Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Formenti Farmaceutici Spa filed Critical Formenti Farmaceutici Spa
Application granted granted Critical
Publication of DK1158963T3 publication Critical patent/DK1158963T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK00910723T 1999-03-05 2000-02-28 Sammensætninger af betahistin med kontrolleret frigivelse DK1158963T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000454A IT1309591B1 (it) 1999-03-05 1999-03-05 Composizioni a rilascio controllato di betaistina.
PCT/EP2000/001642 WO2000053162A1 (en) 1999-03-05 2000-02-28 Controlled-release compositions of betahistine

Publications (1)

Publication Number Publication Date
DK1158963T3 true DK1158963T3 (da) 2003-04-28

Family

ID=11382165

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00910723T DK1158963T3 (da) 1999-03-05 2000-02-28 Sammensætninger af betahistin med kontrolleret frigivelse

Country Status (37)

Country Link
EP (1) EP1158963B1 (da)
JP (1) JP2002538197A (da)
KR (1) KR20010102498A (da)
CN (1) CN1165295C (da)
AR (1) AR029154A1 (da)
AT (1) ATE231392T1 (da)
AU (1) AU762532B2 (da)
BG (1) BG105807A (da)
BR (1) BR0008739A (da)
CA (1) CA2364226A1 (da)
CO (1) CO5170438A1 (da)
CZ (1) CZ299510B6 (da)
DE (1) DE60001266T2 (da)
DK (1) DK1158963T3 (da)
EE (1) EE200100453A (da)
ES (1) ES2189739T3 (da)
GE (1) GEP20033078B (da)
HK (1) HK1042246B (da)
HR (1) HRP20010650A2 (da)
HU (1) HUP0200243A2 (da)
ID (1) ID30127A (da)
IL (1) IL145263A0 (da)
IT (1) IT1309591B1 (da)
MX (1) MXPA01008893A (da)
NO (1) NO319135B1 (da)
NZ (1) NZ513949A (da)
PE (1) PE20001547A1 (da)
PL (1) PL196290B1 (da)
PT (1) PT1158963E (da)
RU (1) RU2248791C2 (da)
SI (1) SI1158963T1 (da)
SK (1) SK284584B6 (da)
TR (1) TR200102566T2 (da)
UA (1) UA65652C2 (da)
WO (1) WO2000053162A1 (da)
YU (1) YU64001A (da)
ZA (1) ZA200107318B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100500130C (zh) * 2003-01-23 2009-06-17 株式会社太平洋 缓释制剂及其制备方法
DK1493435T3 (da) 2003-07-04 2008-09-08 Formenti Farmaceutici Spa Sammensætning af betahistin med styret frigivelse
CA2553309A1 (en) 2004-04-22 2005-11-03 Mor Research Applications Ltd. Method of food intake management
US7728015B2 (en) 2004-04-22 2010-06-01 Mor Research Applications Ltd. Compositions for weight management
WO2006009403A1 (en) * 2004-07-22 2006-01-26 Amorepacific Corporation Sustained-release preparations containing topiramate and the producing method thereof
JP2006176461A (ja) * 2004-12-24 2006-07-06 Dai Ichi Seiyaku Co Ltd 粒状物
ES2419204T3 (es) 2008-05-27 2013-08-19 The University Of Melbourne Métodos para tratar a mamíferos con disfunciones de la trompa de Eustaquio
EP2314296A1 (en) * 2009-10-22 2011-04-27 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Orally Disintegrating Tablets of Betahistine
EP2491930A1 (en) * 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Pharmaceutical combination of betahistine and trimetazidine
DE102012105528A1 (de) 2012-06-25 2014-01-02 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur Freisetzung von Wirkstoffen
WO2015053620A1 (en) * 2013-10-07 2015-04-16 Disphar International B.V. Betahistine composition
PT3431078T (pt) * 2017-07-20 2021-04-21 Intas Pharmaceuticals Ltd Composições orais sólidas de libertação prolongada não pulsáteis de betaistina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2397840B1 (da) * 1977-07-22 1981-03-20 Cherqui Jean
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
ATE277739T1 (de) * 1996-10-28 2004-10-15 Gen Mills Inc Einbettung und einkapselung von teilchen zur kontrollierten abgabe

Also Published As

Publication number Publication date
NZ513949A (en) 2003-10-31
HK1042246A1 (en) 2002-08-09
SK12492001A3 (sk) 2001-12-03
AU3283100A (en) 2000-09-28
GEP20033078B (en) 2003-10-27
EP1158963B1 (en) 2003-01-22
JP2002538197A (ja) 2002-11-12
TR200102566T2 (tr) 2002-01-21
HUP0200243A2 (en) 2002-06-29
PL196290B1 (pl) 2007-12-31
NO319135B1 (no) 2005-06-20
ES2189739T3 (es) 2003-07-16
NO20014301D0 (no) 2001-09-04
AR029154A1 (es) 2003-06-18
PE20001547A1 (es) 2001-01-29
IT1309591B1 (it) 2002-01-24
EP1158963A1 (en) 2001-12-05
ITMI990454A1 (it) 2000-09-05
WO2000053162A1 (en) 2000-09-14
PL350232A1 (en) 2002-11-18
IL145263A0 (en) 2002-06-30
ID30127A (id) 2001-11-08
AU762532B2 (en) 2003-06-26
YU64001A (sh) 2004-05-12
CZ299510B6 (cs) 2008-08-20
DE60001266D1 (de) 2003-02-27
CA2364226A1 (en) 2000-09-14
DE60001266T2 (de) 2003-08-28
HRP20010650A2 (en) 2002-10-31
KR20010102498A (ko) 2001-11-15
MXPA01008893A (es) 2002-10-23
BR0008739A (pt) 2001-12-26
HK1042246B (zh) 2005-06-03
CZ20013186A3 (cs) 2002-02-13
PT1158963E (pt) 2003-06-30
SI1158963T1 (en) 2003-04-30
SK284584B6 (sk) 2005-07-01
BG105807A (bg) 2002-03-29
ATE231392T1 (de) 2003-02-15
CN1165295C (zh) 2004-09-08
CO5170438A1 (es) 2002-06-27
NO20014301L (no) 2001-09-04
UA65652C2 (uk) 2004-04-15
ZA200107318B (en) 2002-09-04
EE200100453A (et) 2002-12-16
CN1342069A (zh) 2002-03-27
RU2248791C2 (ru) 2005-03-27

Similar Documents

Publication Publication Date Title
NO20021540D0 (no) Sammensetninger med kontrollert frigivelse omfattende nimesulfid
DK0922386T3 (da) Sammensætninger med reguleret frigivelse
NO20012857D0 (no) Galantaminsammensetning med kontrollert frigivelse
NO20023672L (no) Sammensetninger for kontrollert frigivelse
DK1142477T3 (da) Sammensætninger med reguleret frigivelse
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1326585T4 (da) Fremgangsmåde til fremstilling af pulverformuleringer
AR027907A1 (es) Composicion de liberacion controlada
DE60013812D1 (de) Schnellkupplung
DK0954966T3 (da) Polymere sammensætninger med reguleret frigivelse
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
DE60038784D1 (de) Schnellkupplung
ATE490327T1 (de) Impfstoffzusammensetzung
DE60025198D1 (de) Stabile biozidale zusammensetzung
NO20014301D0 (no) Sammensetninger med kontrollert frigivelse av betahistin
DK1187833T3 (da) Fremgangsmåde til fremstilling af thiamethoxam
IS6215A (is) Að mestu leyti kristallað form af melagatrani
DK1220858T3 (da) Oxazinoquinoloner der er anvendelige til behandling af virale infektioner
DK1240173T3 (da) Fremgangsmåde til fremstilling af N-phosphonomethylglycin
DK1212095T3 (da) Fremgangsmåde til fremstilling af en formulering med opretholdt frigivelse
DK1345605T3 (da) Varmformet lægemiddelsammensætning til styret afgivelse af perindopril
DK1110518T3 (da) Indretning til forhindring af bruxismus
EP1149892A4 (en) SURFACE ACTIVE COMPOSITION
DK1282598T3 (da) Fremgangsmåde til fremstilling af sulfonyl-benzoylguanidiniumsalte
DE60008950D1 (de) Keramikzusammensetzung